Announced positive topline results from KARISMA-Endoxifen Phase 2 study which demonstrated that low doses of (Z)-endoxifen significantly reduced mammographic breast density (MBD), addressing a key bre ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback